INVA
Innoviva Inc

1,558
Mkt Cap
$2.35B
Volume
442,287.00
52W High
$25.15
52W Low
$16.52
PE Ratio
7.25
INVA Fundamentals
Price
$22.06
Prev Close
$22.15
Open
$22.30
50D MA
$21.37
Beta
0.29
Avg. Volume
905,251.82
EPS (Annual)
$3.30
P/B
1.41
Rev/Employee
$2.67M
$1,396.70
Loading...
Loading...
News
all
press releases
Quantbot Technologies LP Lowers Stake in Innoviva, Inc. $INVA
Quantbot Technologies LP cut its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 67.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities...
MarketBeat·9d ago
News Placeholder
More News
News Placeholder
American Century Companies Inc. Buys 284,253 Shares of Innoviva, Inc. $INVA
American Century Companies Inc. grew its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 13.8% in the third quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·11d ago
News Placeholder
Analysts Offer Predictions for Innoviva FY2027 Earnings
Innoviva, Inc. (NASDAQ:INVA - Free Report) - Research analysts at HC Wainwright issued their FY2027 earnings per share estimates for shares of Innoviva in a report issued on Monday, March 2nd. HC...
MarketBeat·12d ago
News Placeholder
Innoviva, Inc. (NASDAQ:INVA) Receives Average Recommendation of "Moderate Buy" from Brokerages
Innoviva, Inc. (NASDAQ:INVA - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eight ratings firms that are presently covering the company, MarketBeat Ratings...
MarketBeat·19d ago
News Placeholder
Innoviva's (INVA) "Buy" Rating Reiterated at BTIG Research
BTIG Research restated a "buy" rating and issued a $35.00 price target on shares of Innoviva in a research report on Thursday...
MarketBeat·19d ago
News Placeholder
Innoviva (NASDAQ:INVA) Posts Quarterly Earnings Results, Beats Estimates By $1.60 EPS
Innoviva (NASDAQ:INVA - Get Free Report) issued its quarterly earnings results on Wednesday. The biotechnology company reported $1.94 earnings per share for the quarter, topping analysts' consensus...
MarketBeat·20d ago
News Placeholder
Innoviva Reports Fourth Quarter and Full Year 2025 Financial Results; Highlights Recent Company Progress
Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified biopharmaceutical company with a core royalties portfolio, a leading critical care and infectious disease platform known as...
Business Wire·20d ago
News Placeholder
Innoviva (NASDAQ:INVA) Reaches New 52-Week High - Here's What Happened
Innoviva (NASDAQ:INVA) Hits New 1-Year High - Time to Buy...
MarketBeat·20d ago
News Placeholder
Public Sector Pension Investment Board Increases Holdings in Innoviva, Inc. $INVA
Public Sector Pension Investment Board raised its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 24.0% in the third quarter, according to its most recent 13F filing with the...
MarketBeat·24d ago
News Placeholder
Innoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva...
Business Wire·26d ago
<
1
2
...
>

Latest INVA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.